Patrick A. Mayes
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Hematology top 2%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 7
-
- Multiple Myeloma Research and Treatments 5
- Co-authors
- Axel Hoos (3 shared papers)Wafik S. El‐Deiry (9 shared papers)Kenneth W. Hance (1 shared paper)David T. Dicker (7 shared papers)John M. Maris (5 shared papers)Kageaki Kuribayashi (3 shared papers)Nicolas Skuli (2 shared papers)Gabriel S. Krigsfeld (3 shared papers)
- Journals
- Blood (5 papers)Cancer Biology & Therapy (3 papers)Cancer Research (3 papers)Science Translational Medicine (2 papers)Blood Advances (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Patrick A. Mayes
30 papers receiving 3.2k citations
Patrick A. Mayes's Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 845
- Hematology 420
- Neurology 380
- Cancer Research 365
- Genetics 179
Countries citing papers authored by Patrick A. Mayes
This map shows the geographic impact of Patrick A. Mayes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick A. Mayes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick A. Mayes more than expected).
Fields of papers citing papers by Patrick A. Mayes
This network shows the impact of papers produced by Patrick A. Mayes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick A. Mayes. The network helps show where Patrick A. Mayes may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick A. Mayes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma Hit paper breakdown → | 2014 | 423 |
| 2 | 2015 | 394 | |
| 3 | 2012 | 321 | |
| 4 | 2018 | 309 | |
| 5 | 2013 | 291 | |
| 6 | 2010 | 259 | |
| 7 | 2011 | 212 | |
| 8 | 2016 | 150 | |
| 9 | 2010 | 141 | |
| 10 | 2006 | 123 | |
| 11 | 2021 | 95 | |
| 12 | 2008 | 94 | |
| 13 | 2021 | 91 | |
| 14 | 2015 | 88 | |
| 15 | 2010 | 43 | |
| 16 | 2011 | 40 | |
| 17 | 2018 | 34 | |
| 18 | 2022 | 27 | |
| 19 | 2011 | 26 | |
| 20 | 2008 | 24 |
About Patrick A. Mayes
Patrick A. Mayes is a scholar working on Oncology, Hematology, Cancer Research, Neurology and Molecular Biology, having authored 31 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Multiple Myeloma Research and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Neuroblastoma Research and Treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Synthesis and biological activity (2 papers) and Optical Imaging and Spectroscopy Techniques (1 paper). The work is most often cited by research in Oncology (845 citations), Hematology (420 citations), Neurology (380 citations), Cancer Research (365 citations) and Genetics (179 citations). Patrick A. Mayes has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Axel Hoos, Wafik S. El‐Deiry, Kenneth W. Hance, David T. Dicker, John M. Maris, Kageaki Kuribayashi, Nicolas Skuli, Gabriel S. Krigsfeld, Guoliang Qing and Gen Sheng Wu. Their work appears in journals such as Blood, Cancer Biology & Therapy, Cancer Research, Science Translational Medicine and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.